Company intelligence / Profile preview

Changzhou Bone-Renewal Medical Technologies

Changzhou, Jiangsu, Chinachictr.org.cn ↗

Ownership: Private
Development stage: Commercial

Overview

Changzhou Bone-Renewal Medical Technologies specializes in developing and industrializing biomaterials and medical devices for regenerative medicine. Their platform combines sodium hyaluronate modification with German nano-coating technology, leading to commercial-stage products like oral implant biofilms for bone and soft tissue regeneration, and slow-release drug carriers for urinary incontinence.

Therapeutic areas: OtherRheumatologyNephrology
Modalities: DeviceBiomaterial-based therapy
Industry: Surgical Medical Devices

Partnerships

Fourth Military Medical University of Xi'anChina Pharmaceutical UniversityNMI—German Institute for Nature and Medicine

Beyond the preview

Go deeper on Changzhou Bone-Renewal Medical Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Changzhou Bone-Renewal Medical Technologies.

Explore the full profile